ClinicalTrials.Veeva

Menu

Treatment of Periodontitis by Tulsi Gel

A

Al-Azhar University

Status and phase

Not yet enrolling
Phase 3
Phase 2

Conditions

Advanced Periodontitis
Stage III Periodontitis
Stage IV Periodontitis

Treatments

Drug: Chlorhexidine gel
Drug: Tulsi gel

Study type

Interventional

Funder types

Other

Identifiers

NCT06675578
P-ME-24-12

Details and patient eligibility

About

This study will be carried out to compare between the effect of 4%Tulsi gel and 1%Chlorohexidine gel as locally administered agents in the treatment of advanced periodontitis. Clinical parameters measurements, microbiological and radiographic assessment will be performed at base line, one month and 3 months after the intervention.

Enrollment

24 estimated patients

Sex

All

Ages

30 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients included in this study will be having advancedI Periodontitis
  • Aging from 30 to 50 years old
  • Free from any local or systemic risk factors that may affect the results of the study.

Exclusion criteria

  • Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing.
  • Pregnant woman and lactating mothers.
  • Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 2 patient groups

Tulsi Gel group
Active Comparator group
Description:
Ocimum sanctum
Treatment:
Drug: Tulsi gel
Chlorhexidine Gel group
Active Comparator group
Description:
Chlorhexidine
Treatment:
Drug: Chlorhexidine gel

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems